<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:mp ids='MP_0002055'>diabetes</z:mp> have an increased prevalence of premature atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, and alterations in plasma coagulation proteins have been incriminated as a possible cause </plain></SENT>
<SENT sid="1" pm="."><plain>The roles of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> in the pathogenesis of these changes are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>To examine the effects of prolonged <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and of selective <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> on the tissue factor pathway of blood coagulation, nine healthy young men were infused with <z:chebi fb="105" ids="17234">glucose</z:chebi> to maintain levels at 11.1 mmol/l (approximately 200 mg/dl) for 18-72 h (<z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> group) </plain></SENT>
<SENT sid="3" pm="."><plain>Five <z:mpath ids='MPATH_458'>normal</z:mpath> men were infused with regular insulin to maintain levels comparable to that in the previous group (900 pmol/l, approximately 150 microU/ml) and with <z:chebi fb="105" ids="17234">glucose</z:chebi> to maintain levels at 5.6 mmol/l (approximately 100 mg/dl) (euglycemia-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> group) </plain></SENT>
<SENT sid="4" pm="."><plain>Measured were plasma activated factor VII activity (FVIIa), FVII coagulant (FVIIC) activity, FVIII coagulant (FVIIIC) activity, tissue factor pathway inhibitor (TFPI) antigen, and thrombin markers; and serum <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, and electrolytes </plain></SENT>
<SENT sid="5" pm="."><plain>Plasma FVIIa, FVIIC, FVIIIC, and TFPI rose during hyperglycemic-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> but not during euglycemic-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Markers of thrombin generation rose transiently and inconsistently during <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>We concluded that in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> induced activation of the tissue factor pathway, reflected by increases in plasma FVIIa, FVIIC, and TFPI </plain></SENT>
<SENT sid="8" pm="."><plain>This activation was independent of <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, and <z:e sem="disease" ids="C0268009" disease_type="Disease or Syndrome" abbrv="">hyperosmolality</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The elevations in plasma coagulation factors during <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-<z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, characteristic of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, may constitute a potential for enhanced thrombin generation and <z:mp ids='MP_0005048'>thrombosis</z:mp> when triggered by exposure of tissue factor, such as during arterial plaque rupture </plain></SENT>
</text></document>